Judith Eckert

Judith Eckert

Auto-generated profile, based on publicly available information

Judith Eckert

DOHaD Division, School of Medicine, Developmental Cell Biology Group, School, of Biological Sciences, University of Southampton, Bassett Crescent East, Southampton, SO16 7PX, UK

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2007 in BMC Biotechnology
Verified
Journal Article
Open access
PDF file
CHCristina Hartshorn
Cristina Hartshorn
JEJudith J Eckert
Judith J Eckert
OHOdelya Hartung
Odelya Hartung
LWLawrence J Wangh
Lawrence J Wangh
The formation of two distinctive cell lineages in preimplantation mouse embryos is characterized by differential gene expression. The cells of the inner cell mass are pluripotent and express high levels of Oct4 mRNA, which is down-regulated in the surrounding trophectoderm. In contrast, the trophectoderm of female embryos contains Xist mRNA, which is absent from cells of the inner mass. Prior to blastocyst formation, all blastomeres of female embryos still express both of these RNAs. We, thus, postulated that simultaneous quantification of Oct4 and Xist transcripts in individual blastomeres at the 8-cell stage could be informative as to their subsequent fate. Testing this hypothesis, however, presented numerous technical challenges. We overcame these difficulties by combining PurAmp, a single-tube method for RNA preparation and quantification, with LATE-PCR, an advanced form of asymmetric PCR.

1 January 2004
Verified
Closed access
TFTom P. Fleming
Tom P. Fleming
AWAdrian Wilkins
Adrian Wilkins
AMAndrew Mears
Andrew Mears
DMDaniel J Miller
Daniel J Miller
FTFay Thomas
Fay Thomas
JEJudith J Eckert
Judith J Eckert

25 February 2007
Verified
Book Chapter
Closed access
PDF file
BSBhavwanti Sheth
Bhavwanti Sheth
JEJudith Eckert
Judith Eckert
FTFay Thomas
Fay Thomas
TFTom P. Fleming
Tom P. Fleming

1 June 2005
Verified
Book
Closed access
ICIain Cameron
Iain Cameron
SSStephen Smith
Stephen Smith
HJHenry N Jabbour
Henry N Jabbour
KSKurt J Sales
Kurt J Sales
HCHilary Od Critchley
Hilary Od Critchley
ZPZabeena Pandian
Zabeena Pandian
Successful implantation and early development need a union of healthy genes and an optimal uterine environment. The 48th RCOG Study Group, an international multidisciplinary expert forum, considered factors involved in preparation for implantation within the uterus; how to determine a good egg and good sperm; lessons from animal models; transgenic and genomic technologies; sporadic and recurrent early pregnancy loss; single-embryo transfer; and the developmental consequences of assisted reproduction technologies. This book presents the findings of the Study Group, with sections covering:preparation for implantation - the uterine environmentthe embryolessons from animal models (transgenics) and novel technologiesclinical sequelae.

22 August 2016 in Reproduction Abstracts
Verified
Journal Article
Closed access
REReyna Penailillo Escarate
Reyna Penailillo Escarate
MBMark Burton
Mark Burton
GBGraham Burdge
Graham Burdge
JEJudith Eckert
Judith Eckert
TFTom Fleming
Tom Fleming
KLKaren Lillycrop
Karen Lillycrop
Introduction: Women with mutations in BRCA1 gene have an increased lifetime risk of ovarian cancer. Many studies but not all have shown that an adequate folate intake is protective against many cancers including ovarian, but recent studies have shown that high levels of folic acid (FA) supplementation can promote cancer risk. The aim of this study is to determine FA impact on the expression of cancer related genes in the ovary such as OCT4 a pluripotency factor, BRCA1 related to DNA repair and the chromatin modifying enzyme EZH2. Methods: Juvenile (4 wks old) or adult (10 wks old) female C57BL/6 mice were fed for 4 weeks with normal (1 mg/Kg), high (5 mg/Kg) or supramaximal (20 mg/kg) doses of FA and then kept on maintenance diet until 4 or 12 weeks after supplementation. Quantitative RT-PCR was performed to determine the mRNA levels. Results and Discussion: FA supplementation during the juvenile period led to an increase in Oct4, Brca1 and Ezh2 expression immediately after the treatment. However, those effects did not persist after the end of supplementation. In contrast, FA during adulthood led to an increase in Oct4, Brca1 and Ezh2, which persisted 4 weeks after the end of supplementation. These results show that FA affects the expression of cancer related genes in the ovary, but the effects are dependent on the dose and time of supplementation. Future work is needed to identify histological alterations on ovaries and if FA could modify the quality and/or quantity of ovarian follicles.